Ranitidine and Dramamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Dramamine (dimenhydrinate). Common drug interactions include autoimmune disorder among females and convulsion among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Dramamine. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Dramamine?

Dramamine has active ingredients of dimenhydrinate. It is often used in motion sickness. eHealthMe is studying from 1,386 Dramamine users. Check the latest studies of Dramamine.



On Jul, 15, 2026

25 people who take Ranitidine and Dramamine together, and have interactions are studied.

Ranitidine and Dramamine drug interactions.

What are the common drug interactions of Ranitidine and Dramamine, by gender? *:

female:

  1. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  2. Depressed mood
  3. Depression
  4. Dry eye (lack of adequate tears)
  5. Dry mouth
  6. Dysgeusia (disorder of the sense of taste)
  7. Encephalitis (inflammation of the brain)
  8. Memory impairment
  9. Weight decreased
  10. Abscess limb (limb infection)

male:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Headache (pain in head)
  4. Nausea (feeling of having an urge to vomit)
  5. Pulmonary sepsis (pus in lungs)
  6. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  7. Sinus disorder (disease of sinus)
  8. Subcutaneous emphysema (smooth bulging of the skin)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Alanine aminotransferase increased

What are the common drug interactions of Ranitidine and Dramamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Depressed mood
  2. Depression

20-29:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Headache (pain in head)
  5. Nausea (feeling of having an urge to vomit)

30-39:

  1. Bacterial infection
  2. Viral infection

40-49:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Sinus disorder (disease of sinus)
  4. Subcutaneous emphysema (smooth bulging of the skin)
  5. Alanine aminotransferase increased
  6. Aspartate aminotransferase increased
  7. Depressed mood
  8. Depression
  9. Encephalitis (inflammation of the brain)
  10. Hot flush (sudden feelings of heat)

50-59:

n/a

60+:

  1. Abscess limb (limb infection)
  2. Erysipelas (bacterial skin infection)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Chronic kidney disease
  6. Encephalitis (inflammation of the brain)
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 9 people, 36.00%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 24.00%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 24.00%
  4. High Blood Pressure: 6 people, 24.00%
  5. Pain: 5 people, 20.00%
  6. Constipation: 5 people, 20.00%
  7. Indigestion: 5 people, 20.00%
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 16.00%
  9. Hiv Infection: 4 people, 16.00%
  10. Weight Loss: 4 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Dramamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranitidine and Dramamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dramamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dramamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine and dimenhydrinate (the active ingredients of Ranitidine and Dramamine, respectively), and Ranitidine and Dramamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: